According to a recent LinkedIn post from Cagent Vascular Inc, the company is promoting an upcoming live clinical discussion on Serration Remodeling Therapy, or SRT, for peripheral artery disease (PAD). The session, scheduled for Tuesday, March 24 at 8 p.m. EST, features physicians Dr. Peter Schneider, Dr. Vincent DiGiovanni, and Dr. Jeffrey Silpe.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that the event will address how SRT may be changing approaches to PAD care, including rethinking plain old balloon angioplasty (POBA) and exploring new treatment strategies. This type of clinician-focused education may support broader awareness and adoption of Cagent Vascular’s technology, which could be relevant for procedure volumes and long‑term revenue potential.
By positioning SRT as a way to “push the boundaries” of PAD therapy, the post suggests the company is emphasizing innovation within endovascular treatment algorithms. If the discussion helps drive clinical interest and generates real‑world feedback, it could inform future product development and strengthen the firm’s competitive footing in the vascular intervention market.